Anatomic Pathology Market Drivers
Increasing demand from anatomic
pathology service providers as well as from research laboratories (anatomic
pathology research) is expected to drive growth of the Anatomic
Pathology Market over the forecast period.
Innovative product launches and
increasing mergers & acquisition activities has fostered growth of the
anatomic pathology market. For instance, in June 2018, PHC Holdings Corporation
completed acquisition of Anatomical Pathology business of Thermo Fisher
Scientific Inc., The acquired Anatomical Pathology business would operate as a
new stand-alone company named Epredia and will serve as a leading global
provider of comprehensive solutions in the anatomical pathology .
Moreover increasing product
launch is also anticipated to propel the growth of anatomical pathology market
during the forecast period, F. Hoffmann LA Roche Ltd. launched VENTANA DP 200
Slide Scanner in April 2018, which provides high-speed scanning of histology
slides for digital pathology.
Anatomic pathology involves
direct visualization of human tissue as gross examination as well as under a
microscope for proper diagnosis of the disease or a pathological condition.
Subtypes of anatomic pathology include surgical pathology, oral and maxillofacial
pathology, cytopathology, molecular pathology, and forensic pathology.
Procedures performed in anatomic pathology include gross examination,
histopathology, immunohistochemistry, in situ hybridization, cryopathology,
tissue cytogenetics, and others. Standard approach in anatomical pathology is
microscopic examination of tissue samples with the help of one or more stains.
Manufacturers have developed stains to identify and classify microorganisms in
biopsy of tissue samples or excisional specimens. Various gram stains and
acid-fast stains have applications in detection of bacteria and mycobacteria in
tissue samples.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1700
Commercially available products
include tissue processing systems, microtomes, cryostats, and
immunohistochemistry products along with accessories for these products such as
cytology accessories, and microtome accessories. Microtomes are required to cut
tissue block at room temperature with precision, control, and comfort and can
be manually operated, semi-automated, and fully automated. Whereas, Cryostats
are used to cut sections of frozen tissue blocks at subzero temperatures.
Immunohistochemistry involves imaging of antigens in cells of a tissue section
to decipher tissue distribution of an antigen of interest in diseases.
Immunohistochemistry is widely used in diagnosis of cancers, and specifically
expressed tumor antigens are identified. Commercially available anatomic
pathology products include CryoStar NX70 Cryostat, ClearVue Coverslipper, and
Shandon Cytoblock cell block preparation system, Excelsior AS Tissue Processor,
ultraView SISH DNP Detection Kit, Peloris II, and Leica ASP300S.
However, integration of new
technology such as Artificial Intelligence (AI) in pathology is expected to
positively impact growth of the anatomic pathology market over the forecast
period. For instance, Leica Biosystems announced to support a UK government
project to find ways to integrate Artificial Intelligence in pathology
applications in January 2018. Furthermore, Philips and NovoPath Inc. integrated
NovoPath anatomic pathology software platform, and Philips IntelliSite
Pathology Solution and Wholeslide Imaging System in January 2018. Leica
Biosystems, and UCLA Department of Pathology and Laboratory Medicine announced
a collaboration to accelerate adoption of digital pathology in 2016. These
factors are expected to boost the growth of the anatomic pathology market over
the forecast period. Cancer informatics and digital pathology workflow solution
provider Inspirata, Inc. partnered to add latter’s Aperio Digital Pathology
Scanners to formers end-to-end workflow solution portfolio in 2017.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/anatomic-pathology-market-1700
However, limited use of anatomic
pathology solutions is expected to restrain growth of the anatomic pathology market
over the forecast period.
Anatomic Pathology Market
Insights
North America and Europe are
expected to dominate the anatomic pathology market over the forecast period,
owing to presence of various anatomic pathology research institutions
(individual universities such as University of Ottawa, Canada) and diagnostic
laboratories. Moreover, anatomic pathology service providers are present in
both the regions who require these products frequently. Manufacturers such as
ThermoFisher Scientific and Agilent Technologies, Inc. provide advanced
products in the North America region, which fuel growth of the market. Asia
Pacific region is expected to show significant growth over the forecast period,
owing to increasing prevalence of chronic diseases with the need of biopsies
such as cancer. For instance, according to World Health Organization reports
published in 2018, around 4,285,033 new cancer cases were diagnosed in China.
Anatomic Pathology Market
Competitive Landscape
Key players operating in the
global anatomic pathology market include Thermo Fisher Scientific, F.
Hoffman-La Roche AG, Agilent Technologies, Danaher Corporation, Quest
Diagnostics, Inc., Biocartis NV, and Sakura FineTechnical Co., Ltd.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1700
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment